| Item | Cat. No. | Application | Isotype |
| Anti-Staphylococcus aureus Toxin A mAbs [Atidortoxumab Biosimilar] (MABL-4406) | MABL-4406 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Fucosyl-GM1 mAbs [Atigotatug Biosimilar] (MABL-4407) | MABL-4407 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-RTN4/Nogo mAbs [Atinumab Biosimilar] (MABL-4408) | MABL-4408 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-Bet v 1 mAbs [Atisnolerbart Biosimilar] (MABL-4409) | MABL-4409 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-Zaire Ebolavirus Glycoprotein mAbs [Atoltivimab Biosimilar] (MABL-4410) | MABL-4410 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C5AR1/CD88 mAbs [Avdoralimab Biosimilar] (MABL-4411) | MABL-4411 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274 mAbs [Avelumab Biosimilar] (MABL-4412) | MABL-4412 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-SIGLEC3/CD33/p67 mAbs [Avitotamig Biosimilar] (MABL-4413) | MABL-4413 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL21 mAbs [Avizakimab Biosimilar] (MABL-4414) | MABL-4414 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CSF1R/CD115/M-CSFR mAbs [Axatilimab Biosimilar] (MABL-4415) | MABL-4415 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-MMP9/GELB mAbs [Andecaliximab Biosimilar] (MABL-4382) | MABL-4382 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-MSLN mAbs [Anetumab Biosimilar] (MABL-4383) | MABL-4383 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-IFNAR1 mAbs [Anifrolumab Biosimilar] (MABL-4384) | MABL-4384 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Minor Capsid VP2 (Canine) mAbs [Anivovetmab Biosimilar] (MABL-4385) | MABL-4385 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-IL13 mAbs [Anrukinzumab Biosimilar] (MABL-4386) | MABL-4386 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Light Chain Amyloid Fibrils mAbs [Anselamimab Biosimilar] (MABL-4387) | MABL-4387 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NT5E/CALJA/CD73 mAbs [Ansipastobart Biosimilar] (MABL-4388) | MABL-4388 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-Zaire Ebolavirus Glycoprotein mAbs [Ansuvimab Biosimilar] (MABL-4389) | MABL-4389 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CSF3R/CD114 mAbs [Anumigilimab Biosimilar] (MABL-4390) | MABL-4390 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-ERBB2/CD340/HER2 mAbs [Anvatabart Biosimilar] (MABL-4391) | MABL-4391 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
